Global

Immunology Experts

Eiji Hosoi

Professor
Faculty of Medicine
University of Tokushima
Japan

Biography

Eiji Hosoi has done his Doctor of Medicine from Tokushima University in 1993. Currently he is working as Professor in Faculty of Medicine at Tokushima University. His research interests are Blood Transfusion Audit, Immunology Examination, Studies on the expression mechanism of blood group sugar chain antigen in blood cell differentiation process, research on intracellular Ca 2+ signaling of immune cells and its expression (blood group glycan antigen, cell differentiation, immune cell, intracellular Ca 2+ signaling). Several Papers of his work were published in reputed international journals. He is also the member of The Japanese Society of Blood Transfusion, Japanese Association of Medical Technologists, American Assosiation of Blood Banks.

Research Interest

Transfusion Audit, Immunology Examination, Studies on the expression mechanism of blood group sugar chain antigen in blood cell differentiation process, research on intracellular Ca 2+ signaling of immune cells and its expression (blood group glycan antigen, cell differentiation, immune cell, intracellular Ca 2+ signaling).

Publications

  • Wataru Oboshi, Toru Watanabe, Nobuyasu Yukimasa, Ichiro Ueno, Kensaku Aki, Tomoki Tada and Eiji Hosoi. SNPs rs4656317 and rs12071048 located within an enhancer in FCGR3A are in strong linkage disequilibrium with rs396991 and influence NK cell-mediated ADCC by transcriptional regulation. Human Immunology. 2016, 77: 997-1003.

  • Wataru Oboshi, Kensaku Aki, Tomoki Tada, Toru Watanabe, Nobuyasu Yukimasa, Ichiro Ueno, Ken Saito and Eiji Hosoi. Flow Cytometric Evaluation of Surface CD56 Expression on Activated Natural Killer Cells as Functional Marker. The Journal of Medical Investigation : JMI. 2016, 63(3,4): 199-203.

  • Tomoki Tada, Kensaku Aki, Wataru Oboshi, Kazuyoshi Kawazoe, Toshiyuki Yasui and Eiji Hosoi. Evaluation of effects of various drugs on platelet functions using phorbol 12-myristate 13-acetate-induced megakaryocytic human erythroid leukemia cells. Drug Design, Development and Therapy. 2016, 10: 3099-3107.

Global Experts from Japan

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America